This is plausible as IL-17 enhances polymorphonuclear chemotaxis and activation, and is crucially important in mediating mucosal immunity, specifically for systemic Candida infections, which account for 20% of all infections in critically ill patients [32–34]. Here, IL17A is linked to candidiasis.